"Vaccines Work For All: Celebrating World Immunization Week 2024" is a special feature highlighting the essential contributions of vaccine manufacturers in the healthcare sector. As part of World Immunization Week, this initiative aims to recognize the pivotal role played by these manufacturers in advancing global immunization efforts. From pioneering research and development to widespread distribution, vaccine manufacturers are instrumental in safeguarding public health and combating infectious diseases. Through partnerships, innovation, and dedication, these companies work tirelessly to ensure that vaccines are accessible to people of all ages and backgrounds. Join us in celebrating their unwavering commitment to protecting lives and promoting a healthier world for all.

--------------------------------------------------------------------------

Bharat Biotech: Leading the Charge in Global Immunization Efforts

Bharat Biotech (BBIL) is a biotech company in Genome Valley, Hyderabad, India. BBIL is a global leader with 145 patents, ~20 vaccines and bio-therapeutics, and registrations in 125 countries. These vaccines developed with clinical trials in more than 20 countries worldwide and more than 100 publications in peer-reviewed journals. The company has manufactured and supplied more than 9 billion doses of vaccines globally, saving millions of lives and livelihoods annually.

Work Done in Immunization

The company has world-class vaccine and bio-therapeutics research, product development, manufacturing, and distribution facilities. BBIL has developed vaccines for infectious diseases, including Hepatitis B, Pentavalent (DPT+HepB+Hib), Rabies, Typhoid, polio, H1N1 influenza, Japanese Encephalitis (JENVAC®), India’s first Rotavirus vaccine, the world’s first Typhoid conjugate vaccine, TYPBAR TCV®, novel vaccines for covid-19 such as COVAXIN® and INCOVACC®. BBIL introduced WHO pre-qualified vaccines namely BIOPOLIO®, ROTAVAC®, ROTAVAC 5D®, and TYPBAR TCV® in several countries worldwide. BBIL has a strong pipeline of innovative vaccines against Malaria, Cholera, Tuberculosis, Paratyphi A, Non-Typhoidal Salmonella, Chikungunya, Zika, etc. The acquisition of Chiron Behring Vaccines has positioned Bharat Biotech as one of the world's largest rabies vaccine manufacturers with CHIRORAB® and INDIRAB®.

Dr. Krishna Ella, Executive Chairman, Bharat Biotech

Vision: To offer affordable, safe, and effective healthcare solutions to combat mankind’s dreaded illnesses and to thus eradicate or at least control their occurrence in the years to come.

Mission: We seek to address the healthcare needs of the people in emerging markets by driving innovation and being a frontrunner in the research and development of new vaccines and bio-therapeutics.

--------------------------------------------------------------------------

Serum Institute of India: Leading the Global Fight Against Infectious Diseases

Serum Institute of India Pvt. Ltd. (SII) is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, Rubella as well as Pneumococcal and Covid-19 vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by SII. Vaccines manufactured by SII are accredited by the World Health Organization, Geneva, and are being used in around 170 countries across the globe in their national immunization programs, saving millions of lives throughout the world. Serum Institute of India is ranked as India's No. 1 biotechnology company, manufacturing highly specialized life-saving biologicals like vaccines using cutting-edge genetic and cell-based technologies, antisera, and other medical specialties. Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla to manufacture life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus, and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps, and Rubella) group of vaccines. In the global fight against infectious diseases, vaccines stand as one of the most effective tools. Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, has been at the forefront of this battle, producing a vast array of vaccines that cater to a multitude of health needs.

Work done in the immunization sector:

COVID-19 Vaccine - COVISHIELD

COVISHIELD, developed by SII in collaboration with the University of Oxford and AstraZeneca, has been a cornerstone in India's fight against the COVID-19 pandemic. Beyond India, COVISHIELD has been pivotal in global vaccination efforts, widely adopted by numerous countries through international collaborations and supply agreements. Its success lies not just in its ability to protect individuals but also in its contribution to curbing the spread of the virus, facilitating the gradual return to normalcy across the globe.With its robust safety profile, affordability, and broad accessibility, COVISHIELD continues to play a crucial role in safeguarding public health and paving the way towards ending the COVID-19 pandemic.

Bacterial Vaccines: SII offers a comprehensive range of bacterial vaccines that protect against diseases like Diphtheria, Tetanus, and Pertussis.

Viral Vaccines The institute's viral vaccines protect against diseases such as Measles, Mumps, Rubella, and Rotavirus. Combination Vaccines SII has also developed combination vaccines that protect against multiple diseases in a single shot.

HEXASIIL: Protects against Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis & Haemophilus influenzae Type b

Pentavac PFS: Guards against Diphtheria, Tetanus, Pertussis, Hepatitis B, and Haemophilus Type b

Polysaccharide Conjugate Vaccines: SII provides vaccines like the Haemophilus influenzae Type B conjugate Vaccine Influenza Vaccines NASOVAC-S: An Intranasal Influenza Vaccine for Pandemic strains NASOVAC-S4: A seasonal, quadrivalent, live attenuated intranasal influenza vaccine.

--------------------------------------------------------------------------

Central Research Institute: Pioneering Immunization Solutions for Over a Century

CRI, located in Kasauli, Himachal Pradesh, is a pioneering Public Sector Unit of the Government of India, specializing in immunology since 1905. With over 120 years of history, it serves as a vital research center, manufacturing life-saving vaccines and antisera, and providing national-level surveillance for infectious diseases. CRI's contributions include supplying vaccines such as DTWP, DT, TT, AKD, Anti-Rabies, Cholera, JEV, and YFV. Presently, it manufactures and supplies DPT vaccines to UIP and various therapeutic antisera, while also offering diagnostic antigens and antisera for diseases like typhoid and cholera. Collaborating with WHO, CRI conducts surveillance for various viruses and serves as the National reference center for Salmonella typhi and Escherichia coli. Additionally, CRI fosters human resource development through training and academic courses in immunology, microbiology, and vaccinology.

Work Done in Immunizations

From 1906 to 2008, CRI manufactured and supplied rabies vaccine and rabies Serum across the country to meet the 100 % demand thereby providing indigenous treatment of rabies in India. CRI has manufactured and supplied millions of doses of all the above-listed vaccines under various Government Health Programmes. For more than four decades, 70 % of the Nation's demand for various vaccines under UIP was fulfilled by CRI. During World War II, the Institute supplied over a hundred thousand doses of vaccines and antisera per month to the defense forces posted in India, Egypt, and Mesopotamia, which was a record production in those times. During the war years i.e. from 1939 to 1946, manufacturing of vaccines and antisera reached the unprecedented tally of one million doses per month. Currently, the Institute is manufacturing a DPT group of vaccines and has supplied approximately 240 lakh doses (2023-24) of DPT vaccine to the universal immunization program. The Institute supplies the total requirement of yellow fever vaccine of the country, imported through WHO. The Institute is also in the process of production and supply of Td vaccine to UIP. To contribute significantly in National Health Programme as per Vaccine Policy, the institute has planned to expand its vaccines (Both UIP and Non-UIP) horizon to other vaccines such as Japanese Encephalitis Vaccine (JEV), Hib Conjugate, Typhoid Conjugate Vaccine, Meningococcal (Men A/C/Y/W/135) conjugate-Pentavalent, Conjugate Pneumococcal, Hepatitis-B Vaccine, Anti-rabies vaccine (TC-ARV), Human Papilloma Virus (HPV) vaccine and KFD vaccine.

CRI Director’s Message - Dr. Dimple Kasana"The Distance between your dreams and reality is called Discipline"

Central Research Institute, Kasauli has an illustrious past spanning more than a hundred years and has been serving the nation by producing and supplying life-saving Vaccines and Antisera. I began my journey as the Director of this institute in 2021 and feel proud to be associated with this institution, since it has a glorious legacy behind it, and grateful for getting an opportunity to contribute to the pioneering achievements of great scientists like Sir David Semple. As the institute is about to complete its journey of 120 years, I feel confident that CRI will achieve many more milestones in the coming years and will remain a significant body in the health sector of our country. CRI is in the continuous process of commercial production and supply of the DPT vaccine to the Universal Immunization Programme and is all set to manufacture and supply the Td vaccine. CRI has also submitted proposals for the development of cGMP-compliant facilities for various bacterial and viral vaccines to strengthen the Universal Immunization Programme. CRI is also determined to expand its sphere by introducing diverse activities related to applied research in the interest of public health. To achieve this, we are working hard to enhance and upgrade our infrastructure along with building new collaborations. Very soon, we are going to establish a BSL-3 facility at CRI Kasauli, which is going to play a pivotal role in the management of emerging contagious diseases. Working on the vision of India's skill development mission, the institute also runs multiple courses and Industrial training programs to build an educated, trained, and efficient workforce for the future. I assume that with the current technical workforce of CRI, Kasauli, and the guidance and assistance of the Directorate General of Health Services and the Ministry of Health & Family Welfare, we would be able to expand our capabilities in the world of vaccinology.

--------------------------------------------------------------------------

Zydus Lifesciences Limited: Advancing Immunization for Healthier Communities

Zydus Lifesciences Limited, (formerly Cadila Healthcare Limited), holds a prominent position in India's pharmaceutical sector, with a global presence offering comprehensive healthcare solutions. Operating across the pharmaceutical value chain, from formulations to active pharmaceutical ingredients and wellness products, Zydus is renowned for its steadfast commitment to addressing unmet healthcare needs and promoting healthier communities worldwide.

Work Done In Immunization

Under its division Zydus Vaxxicare, the company is deeply dedicated to enhancing immunization rates in India, focusing on diseases such as influenza, typhoid, measles-mumps-rubella, and rabies. By upholding international standards in local vaccine manufacturing strengthening Atma Nirbhar Bharat Abhiyan. Zydus Vaxxicare aims to significantly impact vaccination efforts in the country, engaging healthcare professionals and patients through robust awareness initiatives.

Message From The Leaders Mr. Samir Desai, President -Biologics at Zydus Lifesciences Ltd.: Emphasizes the company's holistic health approach, stressing the pivotal role of vaccination in disease prevention. He highlights the importance of vaccines in combating illnesses like influenza, typhoid, and rabies, emphasizing their contribution to achieving global health objectives, such as ending rabies deaths by 2030.

Mr. Nitin Jain, Vice President of Zydus Vaxxicare and EqualsTwo divisions, echoes this perspective: Emphasizing the crucial nature of vaccination across all age groups, particularly among high-risk populations facing multiple health challenges. He mentions various scientific and awareness initiatives where Zydus collaborates with esteemed medical societies in India, to bolster awareness and medical education within healthcare communities, thus enhancing immunization rates across all age groups.

The enduring memory of COVID-19 vaccination underscores a crucial lesson

Vaccination is not solely for infants and toddlers but extends its benefits to all age groups. Recognizing the importance of vaccination across all demographics, Zydus has initiated its flagship initiative "Life Course vaccination," aiming to prevent vaccine-preventable diseases throughout an individual's lifespan.

Elevating vaccination rates is pivotal in alleviating the burden of vaccine-preventable diseases, particularly in a country like India, where it could significantly impact healthcare burdens. Zydus Lifesciences Limited reaffirms its commitment to advancing public health outcomes and fostering a healthier society for all.

--------------------------------------------------------------------------

Empowering Healthier Futures: AstraZeneca's Commitment to Immunization

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in four therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory and Rare Diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Established in 1979, it is headquartered in Bengaluru, Karnataka, and has a workforce of over 700 employees across the country committed to delivering great medicines to patients through innovative science and global excellence in development and commercialization.

Work Done in Immunization

COVID-19 emerged as a profound challenge in healthcare, prompting AstraZeneca to act swiftly in alignment with our core values-- to follow the science, put patients first, and do the right thing. Our response to the COVID-19 (novel coronavirus) outbreak exemplified our commitment to follow science, prioritize patient care, and uphold ethical standards.

AstraZeneca mobilized its COVID-19 research efforts to focus on key areas: identifying novel coronavirus-neutralizing antibodies against the SARS-CoV-2 virus to prevent or treat disease progression; and investigating the application of our new and existing medicines to suppress the body’s overactive immune response, or protect from serious complications, such as organ failure caused by COVID-19 disease. Our priorities included ensuring the continued supply of our medicines to patients, safeguarding the health and well-being of all our employees as well as communities, and mobilizing our research efforts to discover and deliver solutions against the COVID-19 disease.

Our groundbreaking vaccine development partnership with Oxford University further underlined our commitment to equitable healthcare access, exemplified by our collaboration with Serum Institute in India to ensure broad vaccine availability nationwide. Collaborating globally, including with partners like the Serum Institute of India, we supplied over 3 billion doses of our vaccine at cost, playing a crucial role in the fight against COVID-19, the most significant global health crisis in recent history. The impact was profound, with Vaxzevria estimated to have saved over 6 million lives by December 2021, as per model projections.

We are making progress across our Vaccine and Immune Therapies portfolio and our ambition to deliver long-lasting immunity and protection against infectious diseases that affect millions of people around the world. We are engineering next-generation vaccines that have the potential to generate potent and long-lasting immune responses. For those who cannot mount an immune response to vaccines, AstraZeneca has been pioneering novel approaches to develop highly targeted, long-acting antibodies optimized with our half-life extension technology, which have the potential to play an increasing role in reducing the burden of disease caused by flu, COVID-19 and respiratory syncytial virus (RSV), in addition to other diseases such as cancer and respiratory diseases.

Vision of AstraZeneca

We’re a science-led, patient-focused global pharmaceutical business committed to excellence in the research, development, and commercialization of prescription medicines that aim to transform the lives of patients with improved outcomes and a better quality of life. At AstraZeneca, our vision centers on leveraging science to create innovative therapies, improving the lives of those with chronic diseases. Our strong focus on science drives our pipeline of life-changing medicines, aiming for more effective treatment and prevention of complex diseases. We prioritize specialized disease areas, focusing on cancer, chronic, and rare diseases, where we believe we can make a significant impact. Through our Growth Through Innovation strategy, we're committed to delivering best-in-class medicines across all therapy areas. Our dedication to long-term positive impact and sustained innovation reflects our deep understanding of unmet healthcare needs in India, driving transformative solutions and redefining standards of care. We’re transforming the future of healthcare by unlocking the power of what science can do for people, society, and the planet.

--------------------------------------------------------------------------

Equitable Access to Vaccines: Pfizer's Ongoing Commitment to Global Health

The importance of life course immunization approach and Need for Pneumococcal Vaccination

At Pfizer, we believe vaccination is one of the best ways possible to help protect infants, children, and adults against infectious diseases. We aspire to fundamentally transform infectious disease prevention so that people of all ages can live longer and healthier lives.

Vaccine-preventable diseases are increasingly affecting the Indian population – for instance, India is responsible for 25% of the global pneumonia burden. Fortunately, vaccines form safe, proven, and effective solutions to prevent infection – helping people seek an enhanced quality of life while extending layered protection across the community. This is vital not just in childhood, but across all stages of life, including in adulthood and well into old age, as the protective benefits of childhood vaccines weaken over time.

Pneumococcal disease, a group of illnesses caused by the bacterium Streptococcus pneumoniae (S. pneumoniae), is a leading cause of vaccine-preventable death in children worldwide, with the majority of these deaths occurring in developing countries.

Life-course immunization approach is important

Yet, we must confront a glaring reality: while infants receive due attention in vaccination efforts, the immunization rates among adults in India remain alarmingly low. This may put adults the elderly population (over 50 years of age) and those with comorbidities, including asthma, diabetes, cardiovascular diseases, and more at increased risk of infections such as pneumococcal disease. Life-course immunization is an important, helpful solution to help people lead healthier lives.

At Pfizer, we are leveraging the power of science and our expertise in research and design as we strive to pave the path for a healthier tomorrow. We are committed to helping bridge India’s gap in adult vaccination coverage by creating and championing vaccines as a solution to scale support for public health.

Over the years, Pfizer has made several breakthroughs and led meaningful partnerships and awareness initiatives to advocate for adult vaccination. Through its initiatives, the company has championed patient-centricity in care delivery, ensuring that every at-risk individual who seeks healthcare – whether during routine check-ups, corporate health assessments, outpatient visits, or inpatient care – receives comprehensive education on the critical role that immunization plays in safeguarding health. Additionally, its vaccination solution has been available in India for over a decade.

Building an ecosystem for adult vaccination through the establishment of COEs

Pfizer has also scaled access to adult vaccination across different regions in the country by forging strategic partnerships with over 150 corporate hospitals to establish more than 10 Centers of Excellence (COE), including Royal Care Hospital, Apollo Hospital, and Yashoda Hospitals. These are carefully designed, including redefining protocols and infrastructure, to prioritize preventive health and increase the adoption of adult vaccination. The COEs also empower healthcare practitioners, offering useful information to enhance their understanding of the long-lasting benefits of adult vaccination. These efforts reinforced the convictions of over 4,000+ healthcare practitioners, built the capabilities of more than 500+ nurses, and have created over 100+ vaccination protocols. This is done by sharing resources and upskilling opportunities, as well as by establishing scientific panel discussions and more.

Continuous Medical Education to drive awareness for adult immunization

Pfizer has also introduced educational programs for healthcare professionals and paramedics and has led multiple initiatives to scale access and awareness on the latest up-to-date information on vaccines. It also published a white paper on employee vaccination. Pfizer has led the top-of-mind recall for vaccination with a laser-sharp focus on creating urgency for adults aged 50+ years with its successful Duty@50 campaign and aligning vaccination with treatment goals of HCPs across specialties pulmonologists, nephrologists & CPs.

Our commitment to vaccine innovation and equitable access

Still, we know our work is not done. From changing climates that now allow certain pathogens to thrive and increased movement to urban areas, to people traveling within and across borders, the world faces several realities that all facilitate the transmission of infectious diseases. Working to ensure equitable access and accelerate the availability of potentially life-saving vaccines around the world is a key component of our commitment to improving global health. Our industry-leading pipeline, scientific expertise, and end-to-end global capabilities put Pfizer at the forefront of a new era of vaccine innovation to help address these realities. We continue to advance our leadership in vaccines against pneumococcal and meningococcal disease, deliver breakthroughs to help prevent respiratory syncytial virus (RSV) in older adults and infants from birth through age 6 months through maternal immunization, and explore the potential of vaccines to help protect against other diseases like maternal Group B streptococcus bacteria (GBS) and an mRNA-based flu vaccine. Driving our efforts are the many millions of lives around the world that are depending on us.

Disclaimer: While this feature highlights specific organizations, there are many other vaccine manufacturers playing a crucial role in global immunization efforts.

Dr Shilpa Tatake, Group COO, Jupiter Hospital

She believes health care should be delivered with empathy, transparency, and dignity. The patient is an important stakeholder in the healthcare ecosystem, and s/he should be empowered to be a partner in the healthcare journey as well. She is a strong believer of ‘survival of the fittest’ principle, and tomorrow’s healthcare organizations would only be judged on efficiency, effectivity, and their ability to deliver not only care but also an ‘experience’ to the patient. She takes pride in building strong processes, systems, and an empathetic, ethical healthcare ecosystem in my organization, where the patient is really treated as the ‘First and the most privileged one’.

Neeraj Lal, Chief Operating Officer, Apollo Hospitals, Gujarat Region

Neeraj Lal believes that technological innovations continue to be developed and made available to consumers at breakneck speed. Within this evolving healthcare landscape, care is becoming more personal, more patient-centric, less episodic, more omnipresent, and fully embedded in the lifestyles of the population. Innovative use of digital technologies should create opportunities to enhance patient experience and at the same time optimize care delivery to ensure affordable health access to all. Resulting changes in the fundamentals of healthcare delivery affect all components of the healthcare value chain — from outpatient care enabled through telemedicine, to inpatient care optimized through remote care and home health enabled through digitalization, Internet of Things (IoT), and other interventions].

Sachin Deshmukh, Managing Director (Onco-Life Hospitals)

He believes that there is still a huge gap in healthcare services in tier 2 & tier 3 cities of India. The aim always has been to provide easy access to the best oncology treatment facilities at affordable rates. Throughout the years, spreading awareness via various channels consistently & conducting several medical camps for people in several parts of Maharashtra has helped thousands of patients in early diagnosis & best treatment outcomes

M. Faisal Siddiqui, Chief Operating Officer – Processes, Cancer Treatment Services International, South Asia

He believes in an integrated approach to cancer care on the bedrock of resilient processes & leveraging focused, data-driven technology which enhances the quality of clinical outcomes, and patient’s overall experience and is uniquely poised to create an impact in precision health. 

Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Healthcare

Dr. Emmanuel Rupert is the Managing Director and Group Chief Executive Officer of Narayana Health since 2019. A graduate of BHU, Varanasi, he joined Narayana Health in 2000 as Chief Consultant - Anaesthesia and Director of Academic Services and has since held various clinical and administrative roles, including Group Medical Director, before taking charge of the company in his current capacity. His efforts to offer millions of Indians with affordable, high-quality healthcare are well-known. During the worst of COVID-19, his stewardship was crucial as he strengthened clinical capacity, improved cost management, and streamlined clinical operations to help the organization recover quickly and grow during the past four years. Dr. Rupert has overseen many Narayana Health greenfield and brownfield expansions and is leading the digital transformation to transform Narayana Health into an end-to-end digitally enabled organisation. Dr. Rupert seamlessly blends business acumen with clinical expertise. His ability to strike a balance between these realms sets him apart as a pioneer in healthcare leadership.”

Dr Alok Khullar, CEO, Gleneagles HealthCity, Chennai

Dr. Khullar firmly believes that the patient is always at the centre of the healthcare ecosystem. And therefore in all together he strives to make healthcare delivery more patient-centric, sustainable and more cost-effective. They have been constantly pursuing excellence in care delivery, patient outcomes, and patient-facing empathy while implementing sustainability initiatives to reduce our carbon footprint. They are actively working on promoting a sense of well-being among our doctors and other staff to strengthen healthcare delivery.

Dr Darshan Banker, Chief Interventional Cardiologist & Managing Director, Bankers Group Of Hospitals

Dr. Banker finds immense purpose in making a difference through CPR and First Aid training, ensuring that every individual is equipped with life-saving skills to help anyone in need, especially in public areas. Conducting Cardiology Camps in rural areas amplifies access to crucial heart health insights and educates individuals with limited medical care centres about basic health parameters, disease prevention and hygiene while dispelling myths. In Surat, spearheading free orthopaedic corrective surgeries underscores our commitment to transforming lives. Through health awareness and education camps, they empower communities with knowledge, fostering a healthier tomorrow. “It's not just my profession; it's a journey of impact, compassion, and national wellness”.

Dr Geetika Madan Patel, Vice President, Parul University & Medical Director, Parul Sevashram Hospital

Dr Geetika Madan Patel envisions the attainment of Universal health care in the country in the near future. She dedicates her efforts towards creating a place where quality healthcare is delivered with the utmost compassion to every single patient irrespective of socioeconomic or cultural background. The hospital she heads, Parul Sevashram Hospital, is a 750 bedded NABH accredited digital teaching hospital where technology meets compassion and quality care drives our team’s efforts towards the comfort and healing of our patients and mindful learning for our healthcare students

Abrarali Dalal, Director and CEO, Sahyadri Hospitals

Envisions a healthcare landscape where compassion meets cutting-edge innovation at Sahyadri Hospitals. The journey began with a vision to revolutionize healthcare in Maharashtra, and have consistently delivered world-class medical care, cutting-edge technology, and an unwavering commitment to patient well-being across our 9 Super Specialty hospitals in Western India. Recognizing the pressing need for healthcare in rural India, Sahyadri Hospitals is extending its Quaternary care services to bridge the healthcare gap, providing accessible, high-quality medical services and fostering a healthier future for all."

Dr Simmardeep Gill, MD & CEO Sterling Group of Hospitals, Gujarat

Dr Simmardeep S Gill, manages Sterling Hospitals, a Gujarat-based chain of six hospitals with a presence in Saurashtra, Kutch and Central Gujarat. His team and he are responsible for putting together a team of highly skilled clinical & administrative talent to steer Sterling on the path to becoming a strong pillar towards supporting India’s National Health Mission. The aim is to run stellar clinical programs and simultaneously deliver world-class patient care catering to Gujarat in its entirety and beyond. We are also honoured to support our Govt’s mission of Health for All as almost 30% of our patient volumes are from the PMJAY insurance plans under the aegis of Gujarat Govt. His vision for the coming years is to witness tremendous growth, with Sterling having an ever-expanding footprint in the healthcare industry, delivering exceptional, credible, and easily accessible healthcare.

Jasdeep Singh, Group CEO, CARE Hospitals

Jasdeep Singh is committed to elevating the healthcare ecosystem in non-metropolitan regions by providing high-quality and cost-effective medical services. At CARE Hospitals, the mission is to cater to the healthcare needs of local communities and facilitate opportunities for doctors to return to and practice in their hometowns. This endeavor seeks to create a positive impact on the lives of our patients within the familiarity of their cities, positioning them as a conscientious and transformative healthcare provider

Joy Chakraborty, COO, P D Hinduja Hospital

Joy Chakraborty firmly believes that cost-effective healthcare delivery combined with quality can be provided only when we have strong affirmation of tiers in healthcare especially a strong primary healthcare for the country.

Upasana Arora, Director/CEO, Yashoda Super Specialty Hospital

Upasana Arora is working towards creating an environment where health is right to all quality health care at affordable cost. 

Pankaj Sahni, Group CEO and Director - Medanta (Global Health Limited)

For Pankaj leadership in healthcare is about ensuring that all actions, systems, processes and values are focused on delivering the highest possible quality of healthcare with the right ethics and values. It involves embracing a patient-centric culture of care, promoting continuous learning, innovation and creativity, all the while demonstrating the courage to do what is right.

Dr. D Nageshwar Reddy, Chairman of Asian Institute of Gastroenterology and AIG Hospitals

He is an Indian Gastroenterologist known for spearheading the Gastrointestinal (GI) Endoscopy revolution in the world. In the last four decades, Dr. Reddy’s contribution to therapeutic endoscopy has been immense including the development of a Nagi stent used for biliary drainage. He served as the first Indian President of the World Endoscopy Organization. A staunch believer of affordable, accessible healthcare, Dr. Reddy formed the Asian Healthcare Foundation (AHF), a not-for-profit entity with a dual objective of increasing health coverage across the rural sector and forming robust research capabilities to enhance patient care. He is the first Indian doctor to start a mobile endoscopy unit which would venture into rural places and offer free treatment for several GI related diseases. Over the years, Dr. Reddy has been recognized for his achievements by several societies like he received PADMA BHUSHAN AWARD from the Government of India in 2016, the PADMA SHRI AWARD from Government of India in 2002, B C Roy Award from the Indian Medical Council in 1995 and many more.

Dr. Nomal Chandra Borah, Founder- GNRC Affordable Health Mission and GNRC Group of Hospitals

“I, Dr Nomal Chandra Borah, believe that just by focusing on preventive healthcare, we can prevent 60-70% of diseases prevalent in our society. Early diagnosis and treatment result in better outcomes and less suffering to the patients and families as well as lesser economic burden to the family and the healthcare system. For that, creating healthcare awareness is of utmost importance and GNRC is trying to achieve that with its Affordable Health Mission. The Swasthyamitras (Health Messengers or foot soldiers of this Mission) are working relentlessly to create healthcare awareness among all sections of society. Together, we can achieve a disease-free society and shape a healthy India.” – Dr. Borah 

Dr. K. M Cherian, Founder and Chairman of Frontier Lifeline Hospital and Frontier Mediville

Dr. K. M. Cherian is a world-renowned and distinguished Cardiac Surgeon. He performed India’s first successful Coronary Artery bypass surgery (CABG) in 1975. The country’s first heart transplant after the legalization of brain death, India’s first Heart-Lung Transplant, the first Pediatric Transplant and the first TMR (Laser Heart Surgery) were also performed by him. He was awarded the Padma Shri by the Government of India in 1991. He is the recipient of many prestigious Lifetime Achievement awards conferred by Harvard Medical, Limca Book of World Records, FICCI, Times of India, Indian Association of Cardiovascular Thoracic Surgeons, Paediatric Cardiac Society of India, Government of Kerala, Government of Tamil Nadu & many more. He was awarded his Doctor of Science (Honoris Causa) degree by King George’s Medical University, in 2005. Dr. K.M. Cerian was the honorary surgeon to the President of India from 1990 to 1993. He is the first Indian to become the President of The World Congress of Thoracic Cardiac Surgeons and the first member of The American Association of Thoracic Surgery from India. He also is the first & only Indian, whose name has been carved on a rock at the Island of Kos in Greece, which is the birthplace of Hippocrates, the Father of Medicine.

1. Lindstrom

Lindstrom plays a crucial role in healthcare by leveraging technology to control bio-contamination and enhance hygiene standards. The Service Model aids in ensuring patient safety through advanced garment tracking, minimizing contamination risks and ensuring on-time availability of garments and linen. Moreover, Lindstrom's service fosters personnel engagement, creating a safer and happier work environment, which ultimately benefits both employees and patients alike. 

2. Pristyn Care

Pristyn Care’s vision is to redefine healthcare accessibility. Over the past 5 years, they have collaborated with 700+ hospitals and set up 200+ clinics, addressing medical needs in 40+ cities and served more than a million patients. Their mission is to deliver seamless, comprehensive healthcare services with a focus on patient-centricity. Beyond medical interventions, they manage everything from initial consultations to post-surgical care, insurance claims, and follow-up appointments. Pristyn’s exponential growth is a testament to our commitment to consistent quality care, even in Tier 2 and Tier 3 cities, bridging the healthcare accessibility gap for diverse demographics

3. Monitra Healthcare Pvt. Ltd.

Monitra Health has been at the forefront of creating a significant impact in the healthcare industry. Their dedication to advancing patient monitoring technology is reflected in the successful completion of three pre-clinical studies and one clinical study, with the findings presented at the European Heart Rhythm Association in April 2022. Their business model revolves around establishing upBeat® as the standard for at-home patient monitoring. Looking ahead, we envision expanding our platform into various healthcare sectors, including stroke monitoring, step-down ICU, high-risk pregnancy, clinical research, diabetes monitoring, newborn care, and competitive sports. Monitra Health is poised to reshape the future of healthcare in India and beyond.

4. Orange Health

Orange Health Labs is India's first on-demand, at-home diagnostics company. Its vision is to help doctors diagnose faster and better. The company has re-engineered the diagnostics supply chain and operations to enable getting the fastest possible results for patients. Our innovation is in using cutting-edge technology to enable 60-minute collection at home, continuous reverse logistics, and eliminate batch testing in processing labs. Currently, the company is live across 4 metros in India and has served a million patients and over 1000 clinics.

5. Lupin Digital Health

Lupin Digital Health, a fully owned subsidiary of Lupin Limited, a leading global pharmaceutical company, is dedicated to developing cutting-edge digital health solutions that address unmet patient needs. Our flagship product, Lyfe is a revolutionary digital therapeutics solution that harnesses the power of artificial intelligence (AI) and machine learning (ML) to deliver personalized and immersive patient experiences. Lyfe is India’s 1st clinically proven remote cardiac rehabilitation program designed to improve heart health & quality of life

6. Livofy

Livofy believes in the power of nutrition and supplementation that can help prevent, manage chronic diseases and save lives. Lets make the future of India healthy with what's on your plate. 

7. Medi Buddy

Medi Buddy is an end-to-end digital healthcare platform. They have woven a web of doctors, hospitals, healthcare providers, pharmaceuticals, and insurance companies to create a world of possibilities for people looking for healthcare assistance. Online doctor consultations, lab test bookings, medicine delivery, corporate health and wellness are some of the services they offer. Their mission is to combine the healthcare domain, science, AI technology and human intervention to provide world-class preventive and therapeutic healthcare services.

8.  Qure AI

Qure.ai is a breakthrough Artificial Intelligence (AI) solution provider that is disrupting the radiology 'status quo' by enhancing imaging accuracy and improving health outcomes with the assistance of machine-supported tools. Qure.ai taps deep learning technology to provide automated interpretation of radiology exams like X-rays, CTs and Ultrasounds scans for time and resource-strapped medical imaging professionals—enabling faster diagnosis and speed to treatment. Qure.ai is helping to make healthcare more accessible and affordable to patients worldwide.

9. Lifesigns

LifeSigns is a pioneering force in the Indian Healthcare Industry, transforming the way in which patients are monitored – before hospitalization, in – hospital and post–discharge by leveraging the latest advances in semiconductors, networking, wireless, cloud computing and analytics. LifeSigns is committed to helping the Clinicians & Nursing Staff deliver improved clinical outcomes by employing cutting-edge technologies & complex biomedical and software engineering tools that automate & simplify patient monitoring, no matter where the patients or their Clinical caregivers are located.

1. Indira IVF

“Indira IVF was founded with the mission of creating an infertility-free India through awareness creation and providing affordable, accessible, and assured treatment solutions. Over the last decade, we have helped 140,000-plus couples take a step towards becoming parents by focusing on technologically-driven outcomes. Empathy, compassion and the patient have been at the forefront of this endeavour throughout 120 hospitals. Indira IVF is determined to continue on this journey by developing an ecosystem that nurtures and brings to life the dream of every individual who seeks set on the journey of parenthood.”

2. ART Fertility Clinic

ART Fertility Clinics embarks on a remarkable expansion initiative in India. The progress is anchored in our clinical excellence, cutting-edge research, and technology-driven innovations in Human Reproductive Medicine. The expansion journey represents heightened opportunities and new partnerships in medical fields for individuals aspiring to forge rewarding careers in healthcare, particularly within the specialized domain of fertility and reproductive medicine. 

3. Seeds of Innocens

Seeds of Innocens (SOI) has created a niche for itself in the overcrowded IVF Industry in India, by focusing on the Patient First strategy. Under the able leadership of awe-inspiring Dr. Gauri Agarwal, who is the Founder and also the Chief IVF Specialist, Seeds of Innocens (SOI) has consistently been recognized as one of the most clinically advanced trusted chains of IVF Clinics in North India. It was her vision and foresight, that led SOI to be the First IVF centre in India to establish a Genetic Testing lab. With a focus on reproductive genetics, the clinical team at SOI now consistently delivers a much higher rate of success in IVF due to customised treatment plans aided by the genetic screening process. Chetan Kohli, CEO Seeds of Innocens said: “By utilising the advancement in embryo biopsy and genetic testing of both the intending parent as well as the embryos, the team at SOI has helped several families eradicate genetic diseases from their families, and that has had an undeniable impact on their lives.”

4. Bloom IVF Group

The vision of Bloom IVF Group is to redefine healthcare in India by providing cutting-edge fertility treatments with compassion and precision. We have a highly acclaimed team of internationally trained IVF specialists practicing for over 28 years, with culture of innovation which has led to many firsts in the IVF industry helping in treating repeated IVF failure patients, egg freezing, and male infertility including zero sperm count. Bloom IVF Group’s commitment extends beyond medical expertise; dedicated to creating a positive impact on the lives of patients, ensuring a transformative experience that goes beyond fertility treatment to shape a healthier and happier future for families across the nation. Having centres across India including at Lilavati Hospital Mumbai, DY Patil Hospital Navi Mumbai and Fortis Hospitals Delhi & Chandigarh.

5. Motherhood Fertility

Motherhood Fertility and IVF center is led by a dedicated team of experienced professionals who are committed to providing the best-in-class medical advice and services, with state-of-the-art technology and adherence to strict procedures, the center ensures a safe and supportive environment with high treatment success rates. The mission is to deliver an exceptional healthcare experience to women, children and their families, steered by the highest standard of competence, care and service excellence.

6. Ferty9 Fertility Clinic

“Ferty9 Fertility Clinic is the epitome of cutting-edge fertility solutions, dedicated to turning the dreams of parenthood into a reality for couples facing challenges. Our avant-garde facility, driven by a distinguished team of specialists, offers a spectrum of services from fundamental evaluations to leading-edge Assisted Reproductive Technologies (ART) and personalized counselling. Established in December 2013, Ferty9 stands as a beacon of hope across seven strategic clinics in Andhra Pradesh and Telangana. We not only uphold the pinnacle of ethical standards but ensure an unwavering commitment to providing unparalleled care and support throughout the extraordinary fertility journey of our patients.”

7. Jaslok Hospital & Research Center

“Jaslok Hospital believes in a patient-centric approach where tradition meets innovation to deliver the highest standards of quality clinical care. Vision is to be a beacon for Public Health and to embrace and ethically deliver medical innovations of the future in order to construct a healthier future for India. After five spectacular action-packed decades, Jaslok Hospital and Research Center is anchored in a healing Heritage that spans Generations”

8. Oasis Fertility

Oasis Fertility is a comprehensive healthcare provider with specific attention to infertility treatments. Oasis is a ‘one-stop’ single-day care clinic where consultation, investigation and treatment are taken care of during the course of a single day. Oasis is a unit of the entity Sadguru Healthcare Services Pvt Ltd., which aims to offer state of art services in the Indian healthcare industry by leveraging latest technologies coupled with proven, evidence based international medical practices.

9. Cloudnine Fertility

"At Cloudnine we believed in providing Quality Comprehensive care since inception in 2006. With fertility what we had noticed was that the population seeking fertility treatments in India was much younger than our western counterparts and despite that, we were seeing a success rate of around 33% in most centres. That's when we evaluated and found that Indian doctors are the BEST but their embryology part of the treatment - was NOT. The technology was NOT the latest either. So we imported the latest technology and also had visiting Embryology Consultants Dr Stephen JUNK come over periodically for 6 years to train our TEAM to the international standards. The results were obvious - our success rates were consistently more than 50% - the highest in the country" - Dr. Kishore Kumar, Founder Chairman, Executive Director, Senior Neonatologist, Cloudnine & Harvard Graduate in HealthCare Delivery

10. Nova IVF

Nova IVF Fertility (NIF) is the among the largest service providers in fertility treatment. NIF aims to provide advanced Assisted Reproductive Technology (ART) in India on par as to what is available globally. In addition to providing core procedures such as IUI, IVF and andrology services, NIF offers several state-of-the-art technologies such as vitrification for preserving embryos and eggs, embryoscope and ERA (Endometrial Receptor Array) to find out the timing of the uteruses capacity to accept embryos. With the vast international expertise, NIF offers the same exceptional standard of processes, protocols and policies in India.

1. HealthQuad

“HealthQuad believes that India continues to be plagued by mega healthcare challenges related to accessibility, affordability and quality of care. In resource constrained country like India, the goal of universal healthcare can only be achieved through adoption of disruptive solutions. With a collective experience of more than 200 years in healthcare, a network of 40+ healthcare companies spanning across India, SE Asia and Europe and with a focus on inclusivity, HealthQuad stand as pioneers in healthcare investing, approach being marked by meticulousness, placing significant emphasis on elements that generate positive social impact which goes beyond cohorts that have been traditionally addressed by private investments.”

2.  Alkemi Growth Capital

“Alkemi invests in disruptive healthcare companies changing the status quo. So far Alkemi has invested in 10+ companies across diagnostics, medtech, healthcare delivery etc. Some key investments include Redcliffe Liftech, Doceree, Docquity, Medkart, Saveo etc”

3.  Tata Capital

“As an investor in the healthcare lifesciences sector, Tata Capital Healthcare Fund (TCHF) supports businesses that address the rising opportunity in domestic healthcare consumption and building competency in India for the world. As India’s significantly expanding, middle class will need 3x increase in healthcare spend by the end of the decade and on the other hand India faces a triple challenge of disease burden with Non-Communicable Diseases contributing to 66% deaths in the country. These “2Ds” of Disease and Demographics are the core challenges addressed by TCHF portfolio companies. The fund's portfolio of 15+ companies spans the entire healthcare ecosystem, specifically catering to underserved disease segments like oncology, nephrology, and neuro-psychiatry. Over the past year, TCHF platform has generated a positive measurable impact in-terms of 1.1Mn direct health beneficiaries, 8.2Mn indirect health beneficiaries, 1000+ jobs created and 35% uptick in women employees.”

4.OrbiMed

OrbiMed has been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations spanning from biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting for innovations that will help ensure humanity lives healthier, longer, and more productive lives.

5.  W health Ventures

W Health believes in Building the Future of Healthcare Delivery by investing in and grow tech-enabled early-stage healthcare companies that are disrupting care delivery in the US and India. The Vision is to address the broken healthcare system, which has created large unmet patient needs. W Health Ventures aims to solve critical challenges faced by people due to lack of access, lack of awareness and poor-quality healthcare.

6.  Peak XV Partners

Peak XV Partners (Formerly Sequoia Capital India & SEA) is a leading venture capital and growth investing firm investing across India, South East Asia and beyond. Their approach is to work side by side with founders to help them realise their ambitions. They distil what they’ve learnt and offer it to founders from bespoke advice and support to our cohort and community-based programs such as Surge, Spark, Pathfinders, Pitstop, Build and Guild. The founders of Peak XV partner with generate returns, the majority of which go to our largely non-profit LP base and serve worthwhile causes like preserving our planet, education, fighting poverty and advancing the field of medicine.

7.  Lightspeed Venture Partners

Lightspeed Venture Partners is a multi-stage venture capital firm focused on accelerating disruptive innovations and  a mission to build for India and transform laggard markets and infrastructure in various domains including Healthcare. For over twenty years Lightspeed has been the first investor and an early backer of some of the most innovative companies in the world. In service of bold founders with big ideas, they stand behind their companies with high conviction from Seed to Series F and beyond.

8. Eight Roads Ventures

Eight Roads Ventures is a global venture capital firm backed by Fidelity that helps entrepreneurs scale. They back and partner with game-changing technology and healthcare companies. Their commitment to innovation is global in scale, & they have partnerships with over 300 companies and investment teams across Asia, Europe and the US with 50+ years of venture investing experience. Their unique platform provides entrepreneurs with access to a global ecosystem, to leverage and learn from.

9. Somerset Indus Capital Partners

Somerset Indus is a healthcare-focused private equity firm making private equity and equity-related investments primarily in growth-oriented healthcare companies in India. Its thesis is investing in promoters in tier 2 and 3 cities where real action is. Added to this sustainable, impactful investment with the highest compliance on ESG. Somerset is now invested fully out of its funds 1 and 2 and currently raising fund 3 -200-250 Mn $ with a first close planned by March 24. Somerset is invested by NiiF - India's first and only sovereign fund in addition to DFC etc. Fund 3 has elicited very good response and interest and Kannan Ramesh, senior partner says that the endorsement of a healthcare specialist fund, based on its very good performance and portfolio in funds 1 and 2 is heartening. Somerset will continue to back promoters with a passion to build impactful and sustainable business in India he said.

The brand was founded in 2014, by Deep Bajaj, CEO & Co-founder with a vision to break the stigma around menstrual hygiene and redefine femininity for modern times by offering products that solve unaddressed feminine hygiene issues. Sirona's journey and commitment to creating high-quality, sustainable, and accessible feminine hygiene products focuses on addressing the unique needs of women. Creating products and driving conversations around feminine hygiene problems, Solving all the unaddressed problems from puberty to menopause. while simultaneously promoting environmental consciousness, resonates deeply with everyone. Making informed decisions for holistic well-being.

The journey has seen several milestones in being socially and environmentally responsible: 

Menstrual cups Sold: 20,00,000

Menstrual cups donated: 10,000

PeeBuddy sold: 50,00,000

There is a wide range of period care products like period pain relief patches and roll on, period panties for flow management, sanitary disposal bag, menstrual cup steriliser and cleanser, rash-free sanitary pads, etc. Providing period care, toilet hygiene, and intimate care products, Sirona enhances women's modern lifestyles smoothly and comfortably. Offering all unique and innovative products that help women do what they want without withholding themselves. 

Sirona has set up the Sirona Hygiene Foundation which aims to spread awareness and educate women from all walks of life. Founded in 2014 with one SKU for Peebuddy, and across the years the brand portfolio has expanded horizontally to offer multiple solutions for women with the vision to break the stigma around menstrual hygiene and redefine femininity. SKU’s like PeeBuddy: Sirona's journey began with the introduction of PeeBuddy, a revolutionary product that allows women to stand and pee in public toilets, thereby avoiding contact with unhygienic surfaces. Menstrual Cups: Sirona offers menstrual cups as an eco-friendly alternative to traditional sanitary pads and tampons.Tampons: Sirona provides tampons that are designed to provide comfort, protection, and convenience during menstruation. Herbal Pain Relief Patches: Sirona has developed herbal pain relief patches specifically designed to alleviate menstrual cramps. Intimate Wash and Wipes: Sirona offers intimate wash and wipes formulated with natural ingredients to maintain the pH balance of the intimate area. Pregnancy and Postpartum Products: Sirona recognizes the unique needs of women during pregnancy and postpartum stages. They offer a range of products such as stretch mark creams, nipple care products, breast pads, and disposable underwear to support women during these phases. 

MORE ABOUT THE BRAND

Sirona, an award-winning brand, is acclaimed for changing the feminine hygiene industry by introducing unique products that address unsolved period, intimate, and toilet hygiene issues that women confront from puberty to menopause. Sirona has sold over 18 lakh menstrual cups and over 50 lakh PeeBuddy urination devices. Sirona also offers some ‘India’s first’ innovative products like Period Pain Relief Patch for period pain, PeeBuddy Urination Funnel to assist women to stand and pee in dirty toilets, Oxo-biodegradable Disposal Bags for hygienic disposal of sanitary waste, Rash-free Black Pads, Menstrual Cup Steriliser kits, among other unique products. Sirona products are Toxic-Free, Allergy-Fee, Cruelty-Free, Vegan, and are Made Safe Australia Certified. Sirona also offers India’s first Period Tracker on WhatsApp. The easy-to-use tool helps menstruators across demographics and geographies to keep a tab on their periods just by sending a “Hi” to the Sirona WhatsApp Business Account at +919718866644. The Period tracker can be used to track three goals - track periods, conceive, and avoid pregnancy.

In December 2021, Sirona joined beauty & personal care conglomerate the Good Glamm Group on an aligned vision of scaling the brand using the group’s content-creator-community-commerce moat. In 2022, Sirona also acquired the self-defense brand Impower by Sirona which offers products such as Pepper Spray and Emergency Alarm that come in handy in case you feel a threat to your safety. Recently Sirona also acquired Bleu, India’s First 100% vegan condom brand made from sustainably sourced latex and free from harsh chemicals such as parabens, glycerine, benzocaine, and nitrosamines making them both safe and comfortable for use by both partners.

Take a deeper look at the following aspects:

- Product Innovation: Sirona has gained a reputation for introducing ground-breaking feminine hygiene products. I would love to explore the inspiration behind these innovations, the research and development process, and their impact on improving women's lives.

Sustainability Initiatives: Sirona's emphasis on sustainability is admirable. I am curious to learn more about the company's sustainable practices, such as the use of biodegradable materials and eco-friendly manufacturing processes. Additionally, I am interested in understanding how Sirona educates and empowers women to make environmentally conscious choices regarding feminine hygiene.

- Social Impact: Sirona's commitment to social impact is commendable. I would like to discuss the initiatives taken by Sirona to support women's health and hygiene in underserved communities, and how the company ensures the affordability and accessibility of its products to reach a wider demographic.

- Future Vision: Exploring Sirona's vision for the future of feminine hygiene is essential. I am excited to discuss any upcoming projects, research endeavors, or partnerships that Sirona plans to undertake to continue its mission of empowering women across the globe.

We genuinely believe that shedding light on Sirona's remarkable work will not only inspire and educate individuals but also encourage women to prioritize their health and well-being. The insights gained from this interview will be invaluable in disseminating information to a wider audience, helping to create a positive impact.

INNOVATIVE PRODUCT OFFERINGS

Reusable Menstrual Cup Applicator

It is a revolutionary solution that makes menstrual cup insertion easy and comfortable for menstruators who want to switch to using menstrual cups. The applicator is compatible with Sirona's Small and Medium Menstrual Cups, providing an enhanced and hassle-free experience during menstruation. 

Key features of the Sirona Reusable Menstrual Cup Applicator include:

Easy and Comfortable Insertion: The applicator's rounded top and smooth surface ensure that the menstrual cup can be inserted effortlessly in one go.

Sustainable and Economical: The applicator is designed to last up to 8 years, promoting sustainability. 

FDA Approved and Safe: The Sirona Reusable Menstrual Cup Applicator is FDA-approved, guaranteeing its safety and compliance with rigorous quality standards. It is also free from BPA and latex, ensuring it is safe for use.

Compatible with Sirona Small and Medium Cups: The applicator can be used with Sirona Small & Medium menstrual cups.

To ensure a smooth and pleasant insertion process, it is recommended to use a water-based lubricant with the Sirona Reusable Menstrual Cup Applicator. Sirona is dedicated to providing innovative and high-quality menstrual hygiene solutions that prioritize user comfort and sustainability. The launch of the Sirona Reusable Menstrual Cup Applicator marks another significant milestone in our mission to make menstrual care products accessible, eco-friendly, and empowering for menstruators across India.

Sirona Period Pain Relief Patches

Instant relief from menstrual cramps. Cool patches with no chemicals or side effects. Enriched with the goodness of menthol and eucalyptus oil. An easy solution for period pain. 

TO REACH OUT

Website: https://www.thesirona.com/

Instagram: https://instagram.com/sironahygiene

ONE TRIUMPHANT TEAM, THREE INNOVATIVE MISSIONS

Jivika Healthcare is relentlessly championing the transformative power of compassionate care via innovative solutions. 

MEET THE BRAND 

Jivika Healthcare is a social enterprise aimed at taking healthcare services from hospitals to homes and communities with a motto of “Serving the Underserved”. The big goal is to envision building an affordable, equitable, quality healthcare ecosystem for rural, tribal, and urban communities. 

JOURNEY AND EVOLUTION 

The Jivika Journey began in 2019 with VaccineOnWheels, a first people-centric service innovation. Throughout 4 years of operations, the team has served more than 2.7 million people, across 7 States and 40+ Districts. Having started with one single innovation, today Jivika Healthcare has expanded to 3 service innovations – Cancer Care At Home/Chemo At Home and Healthcare On Wheels, serving communities from all socioeconomic strata, regardless of their backgrounds or geographical location.

DEFINING THE THREE BIG IDEA

Vaccine On Wheels: For the bottom-of-the pyramid children of India, availing the additional 6 vaccines not covered under the Govt. Universal Immunization Program is economically difficult. With an innovative & affordable vaccination model that offers subsidized interest-free EMI vaccination service, Jivika provides additional six vaccines to the underprivileged children. This service also strengthens the Government’s Immunisation penetration as one of the eligibility criteria is that the children must first complete the vaccinations from the Government. 

Cancer Care At Home: CancerCareAtHome is first of its kind service innovation by Jivika Healthcare, serving the cancer patients in Tier III towns and beyond by taking cancer care services to the patients doorsteps. With its social-impact driven care, Jivika delivers Chemotherapy At Home along with other allied services to solve problems of accessibility, affordability and ensure high-quality care continuum for patients residing in Tier III and beyond, where currently there is a huge blank space. 

HealthcareOnWheels: Jivika Healthcare has started on a unique path of providing Mobile Medical Care with a special focus on the most Hard-to-reach & rural Indian areas. Fully equipped with a Doctor, Nursing staff, Healthcare Assistant and experienced healthcare support staff, the organization’s Mobile Medical Unit (known as Swasthya Sawari) is functional in various states – such as Jharkhand and Assam for example. Under the support of CSR, this program is executed in collaboration with Government partnerships, and provides screening, diagnosis, referral & treatment for over 20+ disease conditions. Along with this, Community Mobilizers also travel to villages which are hard-to-reach and motivate community members to take benefit of the services. 

FULFILLING THREE POWERFUL NEED GAPS TO USHER THE FUTURE OF HUMANE HEALTHCARE 

Jivika Healthcare as a parent company with its three service innovations - VaccineOnWheels, ChemoAtHome, and Health & Wellness Center (HWC) On Wheels - is solving three different problems targeting three different population segments. The issues each division is solving are:

VaccineOnWheels(VOW): Every year, 25 million children take birth in India. Out of the fully vaccinated children, 94.5%(NFHS5) take vaccines from the Government. These children are protected against 11 Vaccine Preventable Diseases (VPDs) provided by Government but are left exposed to 6 super-critical diseases not covered under the Government’s UIP. 

CancercareAtHome: Cancer patients often experience physical discomfort and fatigue due to their illness and treatment. Receiving care at home allows them to remain in a familiar and comfortable environment, surrounded by their loved ones. It eliminates the need for frequent hospital visits, reducing the physical and emotional burden on patients and their families. Cancer care at home ensures that patients receive timely and personalized care from healthcare professionals, including doctors, nurses, and caregivers, without the need for hospital admission. It improves access to quality care, especially for those living in remote areas with limited healthcare facilities.

HealthcareOnWheels: The majority of diseases in rural people go undetected due to a lack of screening. 60% of the rural population has to travel more than 5 km to travel to a nearby healthcare facility. Rural areas in India often face geographical challenges such as difficult terrains, inadequate road connectivity, and long distances. This can make it challenging for people to travel to distant healthcare facilities, especially in emergencies. Mobile medical units equipped with necessary medical equipment and staff can navigate these challenges and reach remote areas to provide timely medical assistance.

BRAND DIFFERENTIATOR

1.  Scaling and expansion: In a short span, the organization has scaled geographically along with increased service portfolios. Served 7 States, across 40+ Districts.

2.  Domain Experience: The team carries signature expertise when it comes to serving specific niches and specialized sectors of the society – across silos like geography, age, occupation and other multiple stakeholders.

3.  Operational excellence: The organization is deeply adept at carrying out on-ground, last-mile service delivery with quality of care – and has served more than 2.7 million people so far.

THE BRAND DNA

Vision: “To take care services closer to every community, family and home by building an affordable, equitable, portable (mobile), connected and high-quality healthcare ecosystem for the underserved within urban and rural India.”

Mission: “To serve 25 Million by 2025.”

TESTIMONY OF IMPACT: ONE CAP, MULTIPLE FEATHERS

A list of honours and accolades garnered by Jivika Healthcare over the years.

-  Dissemination Workshop at IIT Delhi, Department of Management Studies on topic “Quality, Equity and Inclusiveness in Healthcare Delivery Service”  

https://indiaeducationdiary.in/iit-delhi-and-jivika-healthcare-dissemination-workshop-on-equity-quality-and-inclusiveness-in-healthcare-service-delivery/ 

-  NATHEALTH - Healthcare Federation of India CSR Award 2023 in the COVID-19 Preparedness & Resilience category, at the much-awaited NATHEALTH Annual Summit 2023.

-  CSR Times Award 2022' - Gold Category in the area of 'Healthcare' at the 9th National CSR Times Summit and Awards 2022, New Delhi.

-  IHW Council Golden Award for Excellent work during COVID at the #IHWAwards.

-  #RIDEStartupoftheYearAward2022 by MIT World Peace University, Pune for achieving exceptional success in the area of Research, Innovation Design and Entrepreneurship (RIDE).

-  Winner of the YourStory Media #TechSparks Top 30 Most Influential Startups for year 2022. The recognition is for our healthcare innovation and exemplary execution in delivering affordable healthcare service to underserved population.

-  The CSR Universe Social Impact Awards 2022 in the Health & Sanitation category.

INTRODUCING THE BRAND LEADERSHIP 

A Brief Profile

Mr. Jignesh Patel: Founder & CEO Mr. Krunal Mehta: Co-Founder & COO

-  VaccineOnWheels: Ankit Singh (Sales & Operations Head), Dr Pramila Mohite (Sr. Operations Manager)

-  CancercareAtHome: Bonnie Mendonca (Sales & Operations Head) & Dr Jyoti Shinde (Onco Expert)

-  HealthcareOnWheels: Sangita More (Program Manager) & Shrinath Bedarkar (Head : M & E Department)

-  Aruna Shirse (CA - Finance Head)

-  Darshit Patel (Chief Digital Officer) 

LEADER QUOTE 

Jivika Healthcare believes in the transformative power of compassionate care and innovative solutions. We strive to be the beacon of hope for the underserved, bringing affordable and accessible healthcare to those most need it. Our commitment to making a positive impact on the lives of individuals and communities drives us every day. Together, we can build a healthier, equitable and more inclusive future for all." - Jignesh Patel, Founder & CEO of Jivika Healthcare.

Brand NirogGyan is empowering patients with meaningful visibility into erstwhile arcane medical reports, amplifying healthcare outcomes exponentially in the process. 

MEET THE BRAND

NirogGyan provides a unique patient engagement platform for healthcare providers that simplifies the medical reports & health data of patients with personalised content and design driven products - providing exceptional education, engagement & experience. 

The brand’s smart products [Report - Video - App] cover over 250 biomarkers, and have touched 5 million lives across 40+ clients (like SRL, 1mg, Max) so far.

THE BRAND DNA

NirogGyan's brand personality can be described as:

Innovative: The team believes in keeping it simple, yet innovative and modern, in a tough industry like healthcare.

Patient-centric: No matter how B2B the format, the products are always ‘human first’: Made for the person who matters the most in healthcare - the Patient.

Reliable: The team makes client satisfaction a non-negotiable priority. The positive word-of-mouth in the Indian industry speaks for itself.

Visionary: NirogGyan supports the United Nations Sustainable Development Goals (SDGs) that aim to achieve Universal Health Coverage by 2030. They believe in ensuring access to quality essential healthcare services and medical information for everyone, regardless of their ability to pay.

VISION > MISSION > PHILOSOPHY 

Vision: To empower every individual with data-driven health awareness and engagement.

Mission: To provide user-friendly and data-driven products for healthcare providers that simplify medical reports and make them more understandable and actionable for patients and doctors.

THE BIG IDEA AND INSPIRATION 

As a healthcare consultant Shweta Gandhi – The brains behind the idea, she is a former healthcare consultant, who worked on various projects with medical giants before identifying this need-gap, spotted gaps in clinical diagnostics, especially on the delivery or patient side. After observing a time-crunched physician checking her mother's lab test report to diagnose sleep apnea, the penny finally dropped : The report is not yet doing its basic job, because all that it contains is some numbers splattered across a piece of paper without any clarity or roadmap for the user. All that rich data was just waiting to be decoded intelligently, so that it could become actually beneficial for the student. Indeed, to every stakeholder in the care ecosystem, if one took the holistic view. 

THE INFLEXION MOMENT 

Goodbye job, Hello grind. With Joyneel's help, Shweta conducted an extensive 3 month-long primary and secondary market research in Delhi NCR, and went on to build the MVP - the first functional Smart Report.

THE NEED GAP BEING FULFILLED 

Digital platforms have come a long way when it comes to providing patients with 24/7 access to critical data and same-day lab results. But viewing raw data rarely translates to extracting optimal value from it. And with Gen Z beginning to age into the healthcare engagement cohort, it’s likely they will increasingly demand personalization, relevance and access, as has been the case with all sectors. Most people are anxious and ill-informed while going through medical reports (as they've traditionally been made just for doctors), leading to a not-that-great checkup experience and suboptimal health outcomes.

The question that Shweta & Joyneel (married couple running the show at NirogGyan) had been asking themselves since a decade was simple, yet profound: How can we connect this data back to the patient in a meaningful way? 

Born through personal crises, NirogGyan responds to the challenge by replacing traditional medical reporting and one-way doctor-patient interaction with a Patient Engagement SaaS for Healthcare Providers that measurably improves health outcomes, amongst other collateral benefits. 

USP’S AND BRAND DIFFERENTIATORS

â—‰ Expertly crafted Smart Reports that can be PDFs, images, or dynamic web pages, instantly accessible on any device

â—‰ Very few companies provide similarly personalized insights on the health status, risk factors, lifestyle, and more for each patient based on their test results, with the help of data visualization and natural language generation

â—‰ A strong B2B focus with multi-template and multi-language options, whitelabel marketing, corporate health dashboard and risk calculators to cater to different needs and preferences of their clients, while causing zero change in their workflow

â—‰ The only startup leveraging cutting-edge Generative AI to create personalised & conversational medical report explainers"

BRAND CUSTODIANS

Quick profile of NirogGyan leadership

Shweta Gandhi — Business Development

Linkedin: linkedin.com/in/shweta-gandhi

Education: MBA, IIM Indore & B Pharma

Work experience: IQVIA, GSK Pharma

Shweta combined her domain knowledge, work experience and passion for Yoga to think up 'biomarker visualisation and storytelling'. She's B2B Sales + Relationship management + Market Research + Medical Content curation, all rolled into one.

Joyneel Acharya — Product & Marketing

Linkedin: linkedin.com/in/joyneel-acharya

Education: MBA, IIM Calcutta & Comp. Sci., BITS Pilani

Work experience: GSK, Mahindra, Galytix (early employee of insurtech startup)

Generalist Joy has brought the product to its current form and loves handling diverse (both tech & non-tech) but talented teams since quite a while now.

WHAT’S NEXT?

This year is dedicated to two flagship products :

1) Viz App (Wikipedia meets Instagram meets Smart Reports): An all in a mobile-first webapp.

2) AI Video Reports:  The brand essence is all about personalising diagnostics-driven patient journeys and delivering outstanding customer experiences. Techies, designers and doctors have therefore converged to pioneer this new product by partnering with Generative AI startup PixAnimate. 

But that’s not all.

FOR BRAND NIROGGYAN, IT’S TIME TO EXPAND GLOBAL FOOTPRINT

After tasting success in India over the past 2 years and some overseas clients acquired organically, the team is now focusing on building a robust GTM that can help it establish a dynamic presence in global markets. 

HONORS AND ACCOLADES PICKED UP 

•   Tide 2.0 grant

•   Accelerated by Upekkha, Incubated in Reliance Jio GenNext and the US Embassy in India

LEADER QUOTE

"Through deeper integrations with top healthcare providers across the globe, we’ll make sure that no preventive or chronic user has unanswered questions around must-know personal information. In the age of ChatGPT, if we can know health statistics in a jiffy, then why not understand and control our health data better?”

*This story is published by VOH team.*

Trizone Healthcare Consultants has been transforming Healthcare Marketing with a Data-Driven Approach and Unmatched Expertise

MEET THE BRAND

Trizone Healthcare Consultants, the first-ever 360-degree branding and marketing full-service consultancy firm in India dedicated to the healthcare and wellness industry, is transforming the way healthcare businesses communicate and grow. With their innovative approach and unparalleled expertise, they are filling the need gap and creating a significant impact in the healthcare sector.

A UNIQUE APPROACH 

Trizone Healthcare Consultants offers an extensive range of capabilities to help healthcare organizations succeed in today's competitive market. Their unique approach combines strategy, creativity, and in-depth industry knowledge to create effective marketing solutions. Trizone's wide array of capabilities includes strategy consulting, marketing branding, advertising and communication design, content writing, website development, digital marketing, social media marketing, audio-video films, training and development, as well as event and conference management.

ONE ROOF. MULTIPLE SOLUTIONS 

By offering a comprehensive suite of services, Trizone Healthcare Consultants provides a one-stop solution for healthcare organizations looking to enhance their brand reputation, attract and retain patients, and drive growth and profitability. Their commitment to listening and understanding clients' needs, combined with their expertise in research, strategy development, and execution, ensures that Trizone is a trusted partner for healthcare organizations seeking to navigate the ever-evolving world of healthcare marketing.

THE BIG IDEA / INSPIRATION 

The inspiration behind Trizone Healthcare Consultants was the realization of a significant need gap in the healthcare marketing sector. Founders Akhil Dave and Niraj Upadhyay, with their vast experience in branding and marketing, recognized that healthcare providers required a dedicated consultancy firm that understood their unique challenges and requirements.

FILLING A NEED GAP 

Trizone Healthcare Consultants is bridging the gap between healthcare providers and the effective marketing strategies. By providing tailored solutions to their clients, they are helping hospitals and clinics grow their revenues, enhance their reputation, and increase patient footfall. Their data-driven approach and extensive experience in the healthcare industry make them the go-to choice for healthcare marketing services.

DECODING THE BRAND DNA

Trizone Healthcare Consultants prides itself on being the perfect blend of knowledge, experience, and passion for healthcare branding and marketing. They place a premium on action, combining it with a deep understanding of the healthcare industry's pain points. Their commitment to their clients is unwavering, and they ensure that their partners receive personalized and result-driven solutions.

VISION – MISSION – PHILOSOPHY 

Trizone Healthcare Consultants' vision is to revolutionize healthcare marketing by providing innovative and result-oriented solutions to their clients. Their mission is to help healthcare businesses grow and thrive in an increasingly competitive market. They believe in the power of knowledge and its application, ensuring that their clients receive the best possible outcomes.

KEY DIFFERENTIATORS: BRAND USPS 

Trizone Healthcare Consultants sets itself apart from the competition through its:

Comprehensive services: They offer a wide range of services, including strategy consulting, branding, advertising, content writing, website development, digital marketing, Social media marketing, Training & Development to Marketing team and more.

Data-driven approach: They rely on data and research to develop customized strategies for their clients, ensuring a high return on investment and long-term success.

Expertise in healthcare marketing: With years of experience working with leading healthcare organizations, they have a deep understanding of the industry and its unique challenges.

Personalized solutions: They recognize that there is no one-size-fits-all solution for healthcare marketing and work closely with their clients to develop bespoke strategies that resonate with their target audience.

THE SIGNATURE APPROACH: A TESTED METHOD THAT DELIVERS CONSISTENT IMPACT 

What sets Trizone Healthcare Consultants apart from the competition is their unique approach to healthcare marketing, which combines strategy, creativity, and in-depth industry knowledge. This approach revolves around the following key traits :

Listen and Understand: The Trizone team takes the time to listen to their clients' needs, challenges, and goals, ensuring a deep understanding of their specific circumstances and requirements.

Analyze & Research: With a strong emphasis on data-driven insights, Trizone conducts comprehensive analyses and research on market trends, competition, and target audience behavior, providing clients with valuable information to make informed decisions.

Design & Develop: Trizone creates bespoke marketing strategies and communication plans tailored to each client's unique needs, leveraging their creative expertise and industry knowledge to deliver effective and engaging campaigns.

Aim & Shoot: With a clear focus on achieving measurable results, Trizone executes their strategies with precision and efficiency, ensuring that clients' objectives are met and exceeded.

Review Results: Trizone continually monitors and evaluates the performance of their campaigns, using data-driven insights to identify areas for improvement and optimize results.

Discover & Reinvent: Always staying ahead of the curve, Trizone embraces change and innovation, adapting their approach and strategies to remain at the forefront of healthcare marketing and ensure their clients continue to thrive in an ever-evolving landscape.

By following this unique approach, Trizone Healthcare Consultants has established itself as a trusted partner for healthcare organizations looking to enhance their brand reputation, attract and retain patients, and drive growth and profitability.

BRAND LEADERSHIP 

Akhil Dave, Founder & Principal Consultant of Trizone Healthcare Consultants, and Niraj Upadhyay, Co-Founder, are accomplished professionals with a wealth of experience in branding, marketing, and strategy. Their leadership has been instrumental in the success of Trizone Healthcare Consultants and the growth of their clients' businesses.

UNIQUE PERSPECTIVE FROM THE BRAND

Challenges The Healthcare Industry Is Facing In Today’s World

In the current scenario patients have more options of healthcare providers/hospitals than ever before. With so much awareness and information available on finger tips and availability and accessibility of healthcare coverage from various Government & Insurance policies, the decision making process over healthcare provider`s selection has changed a lot.

Patients are used to review, research and consider many factors before taking the final decisions over selection of Hospital/Healthcare provider.

That's why it is so important for healthcare providers to plan their marketing strategy at an advanced level where they can retain existing patients and grab new patient footfalls to achieve their Brand & financial goals. 

Here Are 10 More Reasons Why You Need To Invest In Healthcare Consultancy

1.   A dedicated manpower

An institution where saving lives and catering to the healthcare needs of the patient is of utmost priority, it is tough to focus on marketing needs. Here is when consultants come in to play with a dedicated team of professionals.

2.   To direct patient traffic towards you

A team of marketing professionals assist you with the guidance and communication to help you attract patient traffic.

3.   Put the right marketing strategy in place

Apart from knowing what to do, it is also very important to know when and how to do it. A consultancy brings with it, all the answers with strong research as its base.

4.   To build or rebuild your perfect image

Brand image is the first thought that flashes in your mind when you talk about a brand. That thought or visual should be incorporated rightly to create a positive impact. And a consultancy would know exactly how to do it!

5.   To assist you become stronger than your competitor

A consultancy doesn’t just have theoretical knowledge but also knows what works on ground and what doesn’t. It very well understands that one thing you need to do to stand out. 

6.   To help you get better understanding of patients’ behavior 

It is important to know the average patient’s/ their family’s behavior and pattern from the moment of consultation to recovery to retention. The knowledge helps to improve and grow. Here is where you need healthcare consultancy.

7.   To increase your patient engagement

A very key factor that leads to patient retention is patient engagement and a healthcare consultancy can assist you in doing the same. 

8.   Do the healthcare communication right way

Communication is essential in marketing, however it is important to do it right with sensitivity and in a way that it strikes a chord with your audience. 

9.   To benefit from their experience and expertise

A consultancy doesn’t just come with skilled professionals but also experienced experts who’ve worked with corporates and doctors and know exactly what they are doing. You surely can add value to your brand through this knowledge. 

10.   An economic alternative to marketing

A consultancy offers you a complete package of skills, experience, expertise and dedicated manpower at a fixed price that too with a commitment of growth. While building your own marketing team can take a lot more effort and money with an uncertainty of results.

ACCOLADES AND HONORS

Trizone Healthcare Consultants has been involved in numerous successful projects and endeavors, including helping healthcare businesses navigate the challenges of the COVID-19 pandemic. They continue to innovate and adapt to the ever-changing healthcare landscape, with plans to expand their services and reach in the coming years. 

LEADER QUOTE 

"At Trizone Healthcare Consultants, our passion for transforming the healthcare landscape is fueled by a firm belief in the power of effective marketing and branding. We pride ourselves on being catalysts for change, helping healthcare providers not only survive, but thrive in an increasingly competitive and patient-centric environment. Our commitment to understanding, innovation, and collaboration allows us to create tailored solutions that resonate with our clients' values and objectives, ultimately enabling them to build trust and loyalty among their patients. I strongly believe in the principle that 'Knowing is Knowing & Doing is Doing,' meaning that knowledge without application is the same as having no knowledge at all. This conviction guides our approach and ensures that we deliver tangible results for our clients." - Akhil Dave, Founder & Principal Consultant of Trizone Healthcare Consultants LLP

It’s all about MINDSETⓇ, Let’s Change it!

This belief underscores the company's commitment to helping clients transform their approach to marketing and achieving success.

Mr. Niraj Upadhyay Co-founder, the driving force behind Trizone Healthcare Consultants, shares his philosophy on the importance of having the right mindset. He states, 

*This story is published by VOH team.*

Multiple shocks and tectonic shifts spanning from COVID-19, ongoing conflicts, climate change, increasing polarity, and changing demographics all point to the fact that we are sitting at the cusp of entering if not embarking into a new age. To successfully transition and withstand challenges in the transformation it appears by all accounts the key to success is developing resilience. So, what does it entail when applied to healthcare?

Hollnagel et al (2013) define it as “the ability of the healthcare systems (a clinic, a ward, a hospital, a country) to adjust its functioning prior to, during or following events (changes, disturbance and opportunities), and thereby sustain required operations under both expected and unexpected condition”. Crudely put the ability to be a mechanical spring with emotive intelligence in healthcare delivery. To move forward and build resilience we have to first look back.

Chronic underfunding, fragmented health systems, underserved populations, and lack of skilled manpower are well-recognized and acknowledged pain points which have plagued healthcare systems for eons. Added, to the boiling pot are supply chain, manufacturing and distribution blips, nutrition, safe drinking water, demographic changes(ageing population) and rising sceptre of NCD’s and a list of unmet basic needs. Where or what are the probable solutions wherein we could see some green shoots emerge?

Let’s take the first ie chronic underfunding. The current excitement and interest exhibited by private equity in Indian Healthcare delivery ecosystem could perhaps be one such green shoot.

Covid has heralded a transformable change in care delivery models. Alternate sites of care have emerged. It is becoming patient-centric, ambulatory, and available at home; driven by data analytics; enabled by new technologies and attempting to be value-based and transparent. Universal health coverage, and increasing health insurance penetration will press the need for enhancing quality of services and cost reductions. Systems which have high market share will outperform those with low market share as they have economies of scale that drive efficiency. Unfortunately in our context, this would mean that funding will go to well-established metro-centric systems of care. The country is largely served by mid and small sized units and they are the ones who need urgent attention. To achieve digitization, skill sets in management, operational efficiency, and agility in adapting to a new normal there is a need for optimization of back-end functions, and technology enhancement. For healthcare professionals, it would mean learning new skills to manage technology after being convinced of the service or product fit in an Indian context.

Multi-stakeholder and cross-segment alliances will hopefully evolve into new scalable services and business models with greater alignment of incentives, better integration of care, and use of data analytics, technology etc. All of this of course comes at a price for investment and a cost to the patient. 

Proactively and fundamentally reshaping how the industry operates and how care is delivered will feed into the sorely needed resilience required by the country as we move into a new era.